Onderneming Calidi Biotherapeutics, Inc.
Aandelen
CLDI
US3207031010
Biotechnologie & Medisch Onderzoek
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
0,1607 USD | +0,44% | -0,80% | -89,36% |
21/03 | CALIDI BIOTHERAPEUTICS, INC. : HC Wainwright herhaalt koopadvies | ZM |
07/02 | Sectorupdate: Gezondheidszorgaandelen hoger aan het eind van de middag | MT |
Vakgebied
Aantal werknemers: 41
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Allan Camaisa
CEO | Chief Executive Officer | - | - |
Andrew Jackson
DFI | Director of Finance/CFO | 55 | 30-10-23 |
Amish A. Patel
CTO | Chief Tech/Sci/R&D Officer | 47 | 01-08-22 |
Chief Tech/Sci/R&D Officer | 45 | - | |
Wendy Pizarro
ADM | Chief Administrative Officer | 53 | - |
Boris Minev
CTO | Chief Tech/Sci/R&D Officer | 61 | - |
George Ng
BRD | Director/Board Member | 49 | - |
Stephen Thesing
IRC | Investor Relations Contact | - | - |
David Sans
PRN | Corporate Officer/Principal | 55 | - |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
George Ng
BRD | Director/Board Member | 49 | - |
Alan Stewart
BRD | Director/Board Member | 60 | 10-10-23 |
James Schoeneck
BRD | Director/Board Member | 66 | - |
Allan Camaisa
CEO | Chief Executive Officer | - | - |
Scott Leftwich
BRD | Director/Board Member | - | - |
David LaPré
BRD | Director/Board Member | - | 01/01 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 35 726 784 | 19 822 813 ( 55,48 %) | 0 | 55,48 % |
Bedrijfsgegevens
Sector
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-89,36% | 8,15 mln. | |
-2,31% | 103 mld. | |
+0,56% | 95,28 mld. | |
+1,69% | 22,15 mld. | |
-17,37% | 21,02 mld. | |
-9,30% | 18,15 mld. | |
-41,01% | 16,73 mld. | |
-14,85% | 16,05 mld. | |
+3,21% | 13,68 mld. | |
+33,54% | 12,17 mld. |
- Beurs
- Aandelen
- Koers CLDI
- Onderneming Calidi Biotherapeutics, Inc.